Automation of Synthesis in Medicinal Chemistry: Progress and Challenges
- PMID: 32832016
- PMCID: PMC7430952
- DOI: 10.1021/acsmedchemlett.0c00292
Automation of Synthesis in Medicinal Chemistry: Progress and Challenges
Abstract
Since the 1990s, concerted attempts have been made to improve the efficiency of medicinal chemistry synthesis tasks using automation. Although impacts have been seen in some tasks, such as small array synthesis and reaction optimization, many synthesis tasks in medicinal chemistry are still manual. As it has been shown that synthesis technology has a large effect on the properties of the compounds being tested, this review looks at recent research in automation relevant to synthesis in medicinal chemistry. A common theme has been the integration of tasks, as well as the use of increased computing power to access complex automation platforms remotely and to improve synthesis planning software. However, there has been more limited progress in modular tools for the medicinal chemist with a focus on autonomy rather than automation.
Copyright © 2020 American Chemical Society.
Conflict of interest statement
The author declares the following competing financial interest(s): Elizabeth Farrant is an employee and shareholder of New Path Molecular Research.
Figures





References
-
- Merrifield R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85 (14), 2149–2154. 10.1021/ja00897a025. - DOI
-
- Morrell A. I.High Throughput Reaction Screening. In New Synthetic Technologies in Medicinal Chemistry; Farrant E., Ed.; Royal Society of Chemistry: London, 2011; pp 42–62.
LinkOut - more resources
Full Text Sources